Chirag Khatiwala
Vice President - Process Development & Manufacturing Obsidian Therapeutics
Seminars
Wednesday 25th February 2026
Roundtable Discussion: Is Bigger Always Better? Defining the Right Scale to Effectively Balance Yield, Safety & Cost
11:30 am
- Contrasting scalability limitations across vector types and how physical constraints shape commercial strategy
- Discussing trade-offs between driving higher titres versus maintaining potency and how these challenges can differ across vector classes
- Deciding between ‘scaling up’ and ‘scaling out’ and how this can be affected by modality, indication, and regulatory expectation
Thursday 26th February 2026
Chair’s Opening Remarks
8:50 am
